Cellectis CLLS
NASDAQ CLLS
$0.94 -0.03 (-3.25%)
As of: Oct 22, 2026 · 2:36 PM EDT

Cellectis (CLLS) Change in Other Operating Assets (2021 - 2022)

Updated

Analysis

Cellectis (CLLS) Change in Other Operating Assets (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Assets Change (Qtr)
1 Eli Lilly 1,167.69 Bn 1,136.27 Bn 19.71 Bn -
2 Johnson & Johnson 648.01 Bn 567.87 Bn 17.30 Bn -122.00 Mn
3 AbbVie 503.52 Bn 476.63 Bn 12.70 Bn 188.00 Mn
4 Merck 367.68 Bn 322.06 Bn 12.21 Bn -
5 Novartis Ag 303.32 Bn 267.31 Bn 11.24 Bn -
6 Astrazeneca 269.17 Bn 242.86 Bn 12.86 Bn -
7 Amgen 242.30 Bn 197.70 Bn 7.24 Bn 330.00 Mn
8 Gilead Sciences 195.24 Bn 169.44 Bn 6.22 Bn 13.00 Mn
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn -
10 Cellectis 92.59 Mn -660.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -110,000.00
Mar 31, 2021 583,000.00
API Access

Cellectis Change in Other Operating Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-assets&ticker=CLLS&period=max&api_key=YOUR_API_KEY